Table 3.
Clinicopathologic features | Level of immunostaining (IRS) | ||
---|---|---|---|
Low | High | P* | |
Age, years (n = 47) | 0,098 | ||
≤60 | 8 | 12 | |
>60 | 5 | 22 | |
Sex (n = 50) | 0,596 | ||
Women | 8 | 19 | |
Men | 7 | 16 | |
Tumor location (n = 49) | 0,841 | ||
Sigmoid colon | 5 | 16 | |
Left side colon | 1 | 2 | |
Transverse colon | 2 | 4 | |
Right side colon | 7 | 12 | |
TNM stage (n = 50) | 0,025 | ||
I-II | 12 | 16 | |
III-IV | 3 | 19 | |
Grade of differentiation (n = 50) | 0,311 | ||
Well/moderate | 14 | 29 | |
Poor | 1 | 6 | |
Mucinous type (n = 50) | 0,602 | ||
Yes | 4 | 9 | |
No | 11 | 26 | |
Mitotic index (n = 49) | 0,550 | ||
Low | 10 | 26 | |
Moderate-high | 4 | 9 | |
Grade of cell pleomorphism (n = 49) | 0,622 | ||
Low | 6 | 15 | |
Moderate-high | 8 | 20 | |
Peritumoral inflammation (n = 50) | 0,596 | ||
Low | 7 | 16 | |
High | 8 | 19 | |
Lymphovascular invasion (n = 50) | 0,524 | ||
Yes | 1 | 4 | |
No | 14 | 31 |
*Chi-square test; IRS: immunoreactive score; TNM: tumor node metastases.
Bold value indicates statistical significance.